Stockscreener 앱 받기
0.00
100.00%
-0.0973
전일 마감가:
$0.0973
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$120.44M
수익:
$25.19M
순이익/손실:
$-34.53M
주가수익비율:
0.00
EPS:
-0.036
순현금흐름:
$-20.62M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$0.1677
조메디카 Stock (ZOM) Company Profile
명칭
Zomedica Corp
전화
734-369-2555
주소
100 Phoenix Drive, Suite 190, Ann Arbor, MI
ZOM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZOM
Zomedica Corp
|
0.00 | 120.44M | 25.19M | -34.53M | -20.62M | -0.036 |
|
RGC
Regencell Bioscience Holdings Ltd
|
16.07 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
156.16 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.35 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.39 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.77 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
조메디카 Stock (ZOM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-06 | 개시 | Dawson James | Buy |
조메디카 주식(ZOM)의 최신 뉴스
Zomedica Pharmaceuticals Corp. (ZOM.V) (CVE:ZOM) Shares Down 6.6% – Time to Sell? - Defense World
WTR Biotech Spotlight Podcast Recap Zomedica Corp. (ZOMDF) - Smartkarma
Transcript : Zomedica Corp.Special Call - marketscreener.com
Revolutionary Breakthrough: Zomedica's New Equine Insulin Test Eliminates Manual Dilution, Sets Industry Record - Stock Titan
Director’s Bold Move: Massive Stock Purchase in Zomedica! - TipRanks
Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations - ACCESS Newswire
Zomedica Unveils Game-Changing Veterinary Tech Portfolio in New Monthly Expert Webinar Series - Stock Titan
Zomedica Corp. (ZOMDF) Reports Q1 Loss, Lags Revenue Estimates - MSN
Transcript : Zomedica Corp., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com
Zomedica Reports Q1 2025 Growth Amid Strategic Expansion - TipRanks
Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth - ACCESS Newswire
Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split - ACCESS Newswire
Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease - ACCESS Newswire
Zomedica Corp (ZOMDF) Q1 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Zomedica Corp (ZOMDF) Q1 2025 Earnings Report Preview: What To E - GuruFocus
Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy - ACCESS Newswire
Company’s flying speeder bike is like something from ‘Star Wars’ - The Herald Palladium
Zoo uses ‘Blind Date’ technique to get rare animals to mate - The Herald Palladium
Zomedica to Report First Quarter 2025 Financial Results with a Business Update on Thursday, May 15, 2025 at 4:30 pm ET - ACCESS Newswire
The United States Eventing Association Names Zomedica’s PulseVet(R) as the Official Shock Wave of the USEA - ACCESS Newswire
Zomedica CFO resigns, interim replacement named By Investing.com - Investing.com Nigeria
Zomedica CFO resigns, interim replacement named - Investing.com
Zomedica CFO Scott Jordan Resigns, Interim Replacement Named - TipRanks
US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians - ACCESS Newswire
Zomedica Announces Designation of PulseVet® System as the Official Shock Wave Therapy of the National Cutting Horse Association - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors - ACCESS Newswire
Zomedica Corp. Announces Transition to OTCQB Venture Market - ACCESS Newswire
Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System - ACCESS Newswire
Should You Sell IDEXX Laboratories (IDXX)? - Yahoo Finance
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth - ACCESS Newswire
Zomedica Corp. (ZOMDF): Among Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
Is Zomedica Corp. (ZOMDF) the Cheapest Stock Insiders Are Buying In March? - Insider Monkey
15 Cheapest Stocks Insiders Are Buying In March - Insider Monkey
Zscaler, Rocket Lab, American Tower, Intuit, and Zomedica: Insider Moves Unveiled! - TipRanks
Zomedica director Rodney Williams acquires $6,900 in stock By Investing.com - Investing.com Canada
Zomedica director Rodney Williams acquires $6,900 in stock - Investing.com
Zomedica’s CFO Jordan Scott acquires $18,600 in common stock By Investing.com - Investing.com Canada
Zomedica director Christopher MacLeod buys $8,437 in stock - Investing.com India
Zomedica’s CFO Jordan Scott acquires $18,600 in common stock - Investing.com
조메디카 (ZOM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
1.03%
자본화:
|
볼륨(24시간):